Skip to main navigation Skip to search Skip to main content

Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents

  • Stephanie J. Lucas
  • , Rianne Lord
  • , Rachel L. Wilson
  • , Roger M. Phillips
  • , Visuvanathar Sridharan
  • , Patrick C. McGowan

Research output: Contribution to journalArticlepeer-review

93 Citations (Scopus)

Abstract

Several Ru-arene and Ir–Cp* complexes have been prepared incorporating (N,N), (N,O) and (O,O) coordinating bidentate ligands and have been found to be active against both HT-29 and MCF-7 cell lines. By incorporating a biologically active ligand into a metal complex the anti-cancer activity is increased.
Original languageEnglish
Pages (from-to)13800-13802
Number of pages3
JournalDalton Transactions
Volume41
DOIs
Publication statusPublished - 14 Sept 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this